Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Galápagos Almond (Prunus dulcis) contains tocopherols and polyphenols that reduce inflammatory cytokines IL-6, TNF-α, and IFN-γ while modulating gut microbiota composition. Clinical trials demonstrate significant CRP reduction (-0.28 mg/L) and improved cardiovascular markers through mechanisms involving enhanced satiety and metabolic regulation.
Reported Benefits (Provisional)
Origin & History
Galápagos Almond is a unique tree nut native to the Galápagos Islands and coastal regions of South America. It is prized in functional nutrition for its rich profile of monounsaturated fats, polyphenols, and essential minerals, supporting cognitive vitality and metabolic health.
Research Narrative (Provisional)
Emerging scientific studies, including nutritional analyses and preliminary research, support Galápagos Almond's potential for enhancing brain function, cardiovascular health, and metabolic regulation. Further targeted human clinical trials are needed to fully establish its efficacy as a supplement.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Monounsaturated fats (oleic acid, palmitoleic acid), essential amino acids, prebiotic fiber - Vitamins: Tocopherols (Vitamin E) - Minerals: Magnesium, potassium, zinc - Phytochemicals: Polyphenols (quercetin, catechins, gallic acid), plant sterols, saponins, lignans
Reported Mechanism (Provisional)
Tocopherols (alpha-tocopherol, δ-tocopherol, γ-tocopherol) and polyphenols in Galápagos Almonds suppress pro-inflammatory cytokines IL-6, TNF-α, and IFN-γ through cellular anti-inflammatory pathways. The compounds enhance satiety hormone signaling, increase resting energy expenditure, and modulate gut microbiota richness and diversity. These mechanisms collectively reduce systemic inflammation markers like C-reactive protein while improving metabolic efficiency.
Clinical Narrative (Provisional)
Meta-analysis of 11 RCTs with 544 participants showed CRP reduction of -0.28 mg/L (p=0.02) with almond consumption. A 6-week RCT in adults with obesity demonstrated significant decreases in IL-6, TNF-α, and IFN-γ levels (p<0.05) compared to controls. Weight management studies using 42.5-100g daily doses showed minimal weight gain versus predicted increases, with compliant participants achieving significant waist circumference reductions (p≤0.05). Evidence strength is moderate, with ongoing 12-week gut health and 8-week cardiovascular trials needed to confirm long-term efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.